Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Equity (2016 - 2025)

Catalyst Pharmaceuticals' Return on Equity history spans 15 years, with the latest figure at 0.23% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1.0% year-over-year to 0.23%; the TTM value through Dec 2025 reached 0.23%, up 1.0%, while the annual FY2025 figure was 0.25%, 2.0% down from the prior year.
  • Return on Equity reached 0.23% in Q4 2025 per CPRX's latest filing, down from 0.23% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.41% in Q1 2021 to a low of 0.09% in Q2 2024.
  • Average Return on Equity over 5 years is 0.25%, with a median of 0.23% recorded in 2025.
  • Peak YoY movement for Return on Equity: crashed -32bps in 2021, then increased 16bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.19% in 2021, then surged by 82bps to 0.35% in 2022, then plummeted by -59bps to 0.15% in 2023, then surged by 53bps to 0.22% in 2024, then increased by 3bps to 0.23% in 2025.
  • Per Business Quant, the three most recent readings for CPRX's Return on Equity are 0.23% (Q4 2025), 0.23% (Q3 2025), and 0.24% (Q2 2025).